AW Healthcare Beat: Private equity, hedge funds back gene therapy promise
RNA-based therapies and data platforms geared toward oncology treatment are among the deals done in this week’s installment of the Alts Watch Healthcare Beat.
The partnership, two PIPEs and other financing deals totaled over $500 million, according to our tally of all financing deals of $40 million-plus for the week ending February 7.
Leading investors were hedge fund firms Adage Capital and Farallon Capital as well as Surveyor Capital, a unit of . . .
Continue Reading
Unlock this article instantly, along with the rest of our premium content, newsletters and data tables tracking investor and manager activity. Monthly and annual subs available. Research articles require an Annual sub.
